US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

FUNDX FUTURE FUND OPPORTUNITIES ETF

28.66

+0.19000.67%

Volume:10.19K

Turnover:292.29K

Market Cap:233.44M

PE:- -

High:28.70

Open:28.66

Low:28.66

Close:28.47

52wk High:31.30

52wk Low:25.44

Shares:8.15M

Float Shares:8.15M

Volume Ratio:0.66

T/O Rate:0.13%

Dividend:0.50

Dividend Rate:1.73%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Halozyme Therapeutics - Eligible for Milestone Payments and Royalties on Enhanze Product Sales

THOMSON REUTERS

Halozyme Announces Expansion of Global Collaboration and License Agreement with Argenx to Support the Development of Subcutaneous Formulations for Two Additional Exclusive Targets Using Its Enhanze® Technology

THOMSON REUTERS

Halozyme Therapeutics - Increases Argenx's Exclusive Access to Enhanze Increased from Six to Eight Targets

THOMSON REUTERS

Guardant Health Inc Stock (GH) Moved Down by 8.27% on Oct 6: What Investors Need To Know

Guardant Health reports COSMOS study published in Cancer Research Communications

Guardant Health Cosmos-MEL01 Study Shows Guardant Reveal Detects 81% of Distant Melanoma Recurrences

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly

Halozyme Therapeutics (HALO) Adds Jim Daly As Valuation Questions Follow

Simply Wall St.

Halozyme Names James M. Daly as Director

Halozyme Director Matthew L. Posard Sells USD 569,752 Common Shares

Guardant Health price target raised to $200 from $190 at Guggenheim

Halozyme Appoints Jim Daly to Board of Directors

Halozyme Announces Appointment of Jim Daly to Its Board of Directors

THOMSON REUTERS

Guardant Health (GH) Receives a Buy from Bernstein

FDA Advisors Said it Should Approve the Grail Multicancer Blood Test. the Stock Rises Sharply.

Halozyme Prices USD 1.5 Billion 1.5% Convertible Senior Notes Due 2033

U.S. Stocks on the MOVE-Halozyme Therapeutics, Etsy, Netflix

Halozyme Therapeutics Hits Fresh Record After Increased $1.3 Bln Convertible Bond Sale

Pound and Dollar Gold Prices Reflect Divergent Rate Expectations

Halozyme Prices Upsized USD 1.3 Billion Convertible Senior Notes Offering Due 2033

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/FFOX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FFOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FFOX\",,,,,undefined,":{"symbol":"FFOX","market":"US","secType":"STK","nameCN":"FUNDX FUTURE FUND OPPORTUNITIES ETF","latestPrice":28.66,"timestamp":1791576000000,"preClose":28.47,"halted":0,"volume":10189,"delay":0,"changeRate":0.0066736916051985,"floatShares":8145000,"shares":8145000,"eps":0,"marketStatus":"Post-Mkt","change":0.19,"latestTime":"10-09 16:37:53 EDT","open":28.66,"high":28.7,"low":28.66,"amount":292286,"amplitude":0.001405,"askPrice":38.93,"askSize":100,"bidPrice":19.66,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":28.47,"sharesOutstanding":7155000,"nav":28.52,"aum":233436200,"dividendRate":0.017285,"bidAskSpread":0,"volumeRatio":0.658706},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FFOX\",,,,,undefined,":{"symbol":"FFOX","floatShares":8145000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.658706,"shares":8145000,"dividePrice":0.4954,"high":28.7,"amplitude":0.001405,"preClose":28.47,"low":28.66,"week52Low":25.44,"pbRate":"--","week52High":31.295,"institutionHeld":0,"latestPrice":28.66,"eps":0,"divideRate":0.017285,"volume":10189,"delay":0,"ttmEps":0,"open":28.66,"prevYearClose":27.27,"prevWeekClose":28.7858,"prevMonthClose":28.24,"prevQuarterClose":28.24,"fiveDayClose":28.7858,"twentyDayClose":28.55,"sixtyDayClose":29.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FFOX\",params:#limit:5,,,undefined,":[{"date":"2025-12-31","symbol":"FFOX","amount":0.49447507,"announcedDate":"2025-12-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-31","defaultRemindTime":1767191400000,"name":"FUNDX FUTURE FUND OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-02","payableDate":"2025-12-31","currency":"USD","dateTimestamp":1767157200000,"payDate":"2026-01-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FFOX\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-31","recordDate":"2025-12-31","paymentDate":"2026-01-02","value":0.49447507,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FFOX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FFOX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673502063","title":"Halozyme Therapeutics - Eligible for Milestone Payments and Royalties on Enhanze Product Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2673502063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673502063?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:05","pubTimestamp":1791317100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA2N1Z24:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FFOX","BK4139","LU0053671581.USD","HALO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673063687","title":"Halozyme Announces Expansion of Global Collaboration and License Agreement with Argenx to Support the Development of Subcutaneous Formulations for Two Additional Exclusive Targets Using Its Enhanze® Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2673063687","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673063687?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:05","pubTimestamp":1791317100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA2N1Z24:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FFOX","LU0053671581.USD","HALO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673063685","title":"Halozyme Therapeutics - Increases Argenx's Exclusive Access to Enhanze Increased from Six to Eight Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=2673063685","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673063685?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:05","pubTimestamp":1791317100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nTUA2N1Z24:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FFOX","LU0053671581.USD","HALO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673068758","title":"Guardant Health Inc Stock (GH) Moved Down by 8.27% on Oct 6: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2673068758","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673068758?lang=en_us&edition=fundamental","pubTime":"2026-10-07 03:15","pubTimestamp":1791314128,"startTime":"0","endTime":"0","summary":"• Guardant Health shares dropped due to profit-taking after a multi-month rally.\n• Ongoing unprofitability and high valuation multiples triggered intense selling pressure.\n• The company reported $982.02M in annual revenue and a net profit of $-416.28M.","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262202416-market-movers-gh-20261006","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4585","BK4551","BK4196","LU0889565916.HKD","BK4588","GH","LU0320765992.SGD","GNOM","BK4535","EKG","FFOX","HELX","PTH","LFSC","GDOC","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085570","title":"Guardant Health reports COSMOS study published in Cancer Research Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085570","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085570?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:30","pubTimestamp":1791214209,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) announced Cancer Research Communications, a journal of the American Association for Cancer Research, has published results fro...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-reports-cosmos-study-published-in-cancer-research-communications-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-reports-cosmos-study-published-in-cancer-research-communications-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","BK4588","GDOC","BK4551","EKG","PTH","BK4535","GNOM","GNMX","LFSC","LU0109394709.USD","LU0889565916.HKD","GH","LU0320765992.SGD","BK4585","FFOX","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673085807","title":"Guardant Health Cosmos-MEL01 Study Shows Guardant Reveal Detects 81% of Distant Melanoma Recurrences","url":"https://stock-news.laohu8.com/highlight/detail?id=2673085807","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673085807?lang=en_us&edition=fundamental","pubTime":"2026-10-05 23:27","pubTimestamp":1791214069,"startTime":"0","endTime":"0","summary":"Guardant Health COSMOS-MEL01 study shows Guardant Reveal detects 81% of distant melanoma recurrencesGuardant Health disclosed published results from a prospective, multicenter COSMOS study evaluating ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL5cqdWm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LFSC","GNMX","BK4535","GH","BK4196","GDOC","BK4585","EKG","FFOX","GNOM","PTH","BK4588","BK4551","LU0320765992.SGD","LU0109394709.USD","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673702771","title":"Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly","url":"https://stock-news.laohu8.com/highlight/detail?id=2673702771","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673702771?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:00","pubTimestamp":1791201600,"startTime":"0","endTime":"0","summary":"Trial follows promising MAR002 Phase 1 clinical trial results that demonstrated deep and durable IGF-1 suppression with PK properties that may enable dosing as infrequently as once every two weeks, co","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/05/3374474/18623/en/marea-therapeutics-a-subsidiary-of-lisata-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-mar002-a-potential-best-in-disease-investigational-therapy-for-the.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4535","ENDO","BK4551","KBWY","GNOM","PTH","LU0889565916.HKD","LU0320765992.SGD","PK","BK4585","GH","BK4007","EKG","HELX","LENZ","FFOX","BK4588","BK4196","LFSC","LU0109394709.USD","BK4218","BK4181","BK4183","GNMX","GDOC","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672773622","title":"Halozyme Therapeutics (HALO) Adds Jim Daly As Valuation Questions Follow","url":"https://stock-news.laohu8.com/highlight/detail?id=2672773622","media":"Simply Wall St.","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672773622?lang=en_us&edition=fundamental","pubTime":"2026-10-04 21:16","pubTimestamp":1791119768,"startTime":"0","endTime":"0","summary":"Halozyme Therapeutics (HALO) stock is back in focus after the company appointed veteran biopharma executive James “Jim” Daly to its Board of Directors, giving investors fresh data to assess boardroom experience.\nAt a share price of US$109.86, Halozyme Therapeutics has seen a 36% 90 day share price return and a 56.25% year to date share price return, while the 1 year total shareholder return of 59.26% and 3 year total shareholder return of 194.77% point to momentum that investors are still...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-halo/halozyme-therapeutics/news/halozyme-therapeutics-halo-adds-jim-daly-as-valuation-questi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-halo/halozyme-therapeutics/news/halozyme-therapeutics-halo-adds-jim-daly-as-valuation-questi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FFOX","LU0053671581.USD","BK4139","HALO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672471749","title":"Halozyme Names James M. Daly as Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2672471749","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672471749?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:43","pubTimestamp":1790973786,"startTime":"0","endTime":"0","summary":"Halozyme names James M. Daly as directorHalozyme Therapeutics named James M. Daly to its board, triggering an initial insider ownership filing dated Sept. 28, 2026.The filing lists Daly as a director.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL3lTKYB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","FFOX","BK4139","HALO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672749155","title":"Halozyme Director Matthew L. Posard Sells USD 569,752 Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2672749155","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672749155?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:39","pubTimestamp":1790973549,"startTime":"0","endTime":"0","summary":"Halozyme director Matthew L. Posard sells USD 569,752 common sharesHalozyme Therapeutics director Matthew L. Posard sold 5,230 common shares on Oct. 1, 2026.Sales prices ranged from $107.168 to $110.0","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL4KvQdq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Halozyme Director Matthew L. Posard Sells USD 569,752 Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFOX","LU0053671581.USD","HALO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672520357","title":"Guardant Health price target raised to $200 from $190 at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2672520357","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672520357?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:37","pubTimestamp":1790858259,"startTime":"0","endTime":"0","summary":"Guggenheim raised the firm’s price target on Guardant Health (GH) to $200 from $190 and keeps a Buy rating on the shares. The firm adjusted its mod...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-200-from-190-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guardant-health-price-target-raised-to-200-from-190-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNOM","LU0320765992.SGD","BK4535","LU0889565916.HKD","HELX","BK4196","PTH","GNMX","BK4588","LU0109394709.USD","GDOC","GH","LFSC","EKG","FFOX","BK4551","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672782583","title":"Halozyme Appoints Jim Daly to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672782583","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672782583?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:08","pubTimestamp":1790798915,"startTime":"0","endTime":"0","summary":"Halozyme appoints Jim Daly to board of directorsHalozyme appointed James “Jim” Daly to its board of directors.Daly was Incyte’s executive vice president and chief commercial officer from 2012 to 2015.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDLbLVFZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670756490.USD","SG9999001176.USD","LU0971552830.HKD","IE00BWDBJ516.SGD","GSK.UK","LU1400636574.HKD","IE00B3T34201.USD","LU1645745479.HKD","LU0289739699.SGD","LU0971552673.USD","LU1400636657.SGD","FFOX","IDNA","LU0161305163.EUR","LU0987226296.USD","LU0211331839.USD","LU0203345920.USD","LU1302929846.USD","LU0985481810.HKD","LU0225771236.USD","LU1228905037.USD","LU2646069778.SGD","IE0034235071.USD","SG9999001176.SGD","LU1983299246.USD","BK4585","SGXZ57979304.SGD","BK4139","HALO","LU0306806265.USD","LU0321505868.SGD","LU1202635105.USD","BK4588","LU1400636491.USD","BK5011","LU0225283273.USD","LU2089984988.USD","LU0557290698.USD","LU1481600234.SGD","SG9999013999.USD","LU0306807586.USD","LU1035777561.USD","LU1309081286.SGD","LU1046248800.SGD","LU1481599808.USD","LU1487256676.USD","LU1098665638.USD","LU0545562505.USD","INCY","LU0225284248.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672978282","title":"Halozyme Announces Appointment of Jim Daly to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672978282","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672978282?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:05","pubTimestamp":1790798701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUA4XRWY0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FFOX","BK4139","LU0053671581.USD","HALO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670745514","title":"Guardant Health (GH) Receives a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2670745514","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670745514?lang=en_us&edition=fundamental","pubTime":"2026-09-26 22:15","pubTimestamp":1790432125,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Eve Burstein from Bernstein maintained a Buy rating on Guardant Health, with a price target of $210.00. The company...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guardant-health-gh-receives-a-buy-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guardant-health-gh-receives-a-buy-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFSC","FFOX","BK4588","BK4551","BK4196","EKG","GNOM","LU0889565916.HKD","LU0109394709.USD","GH","BK4585","GNMX","BK4535","HELX","LU0320765992.SGD","GDOC","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669499070","title":"FDA Advisors Said it Should Approve the Grail Multicancer Blood Test. the Stock Rises Sharply.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669499070","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669499070?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:52","pubTimestamp":1790261520,"startTime":"0","endTime":"0","summary":"Mizuho's Bradley Bowers thinks the boost will be substantial. He wrote Tuesday that sales doubled in the launch years of other cancer-screening products-like colon cancer stool test Cologuard from the Exact Sciences unit of Abbott, or the colon cancer blood test Shield from Guardant Health.Galleri screens a person's blood sample for bits of DNA showing features typical of cancer cells. It tells you if it has found a general signal of cancer somewhere in your body-\"Cancer Signal Detected\"-and makes its best guess at the kind of tissue where the cancer is hiding.Clinical trials showed Galleri can detect cancers for which there is no standard screen, such as cancer of the ovary or pancreas. Grail's two big clinical trials showed that it rarely tells you that you have cancer when you don't. When you do have cancer, the test finds it on average about 50% of the 60% of the time.That is good performance, compared with other widely used screens, like the mammogram. Grail plans to tell customer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE00B4R5TH58.HKD","LABU","BK4568","LU0889565916.HKD","GNMX","SGXZ41872573.SGD","IE00B2B36J28.USD","LU2237957811.SGD","LU2468319806.SGD","LU2089984988.USD","BK4082","EKG","TMED","LU1989763690.USD","ABT","BK4139","BK4588","GH","IE0002141913.USD","IHI","LU0320765489.SGD","BK4535","SG9999002224.SGD","LU2112291526.USD","LFSC","BK4551","LU1670627923.USD","LU0211331839.USD","BK4196","BK4581","GNOM","LU0289739699.SGD","SG9999002232.USD","PJP","LU0882574055.USD","LU2324357040.USD","SGXZ23171101.USD","LU1691799644.USD","BK4585","GRAL","FFOX","PTH","LU0868494617.USD","LU1721429402.USD","LU1721429741.USD","SG9999004303.SGD","HELX","LU1061106388.HKD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669512270","title":"Halozyme Prices USD 1.5 Billion 1.5% Convertible Senior Notes Due 2033","url":"https://stock-news.laohu8.com/highlight/detail?id=2669512270","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669512270?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:41","pubTimestamp":1790109709,"startTime":"0","endTime":"0","summary":"Halozyme prices USD 1.5 billion 1.5% convertible senior notes due 2033Halozyme priced and closed a private placement of USD 1.5 billion 1.5% Convertible Senior Notes due 2033 on Sept. 22, 2026.Net pro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL44SpQP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFOX","LU0053671581.USD","HALO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668922682","title":"U.S. Stocks on the MOVE-Halozyme Therapeutics, Etsy, Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2668922682","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668922682?lang=en_us&edition=fundamental","pubTime":"2026-09-18 23:52","pubTimestamp":1789746775,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Halozyme Therapeutics, Etsy, NetflixSeptember 18 (Reuters)-Wall Street's main indexes fell on Friday in the final stretch of a turbulent week, as investors assessed shifti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL6N45A0YO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UMI","AFK","ETSY","NUE","CORD","LU2361045086.USD","IBRN","CRWV","CWII","DT","GDX","MLPX","CRWX","FFOX","CRWU","TPZ","SLX","NEM","SGDM","XENE","SBIO","SLVP","TRGP","CRWG","GLDN","FMTL","GDMN","LU0788108826.HKD","BK4209","AGMI","PICK","STUB","AU","DSP","CWVX","HALO","LU1223082519.USD","LU0278409577.USD","NWMX","AUAU","AUMI","CAVA","STLD","LU0154245673.USD","NEMG","PXI","BK4570","PYZ","TRUM","MLPI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668892177","title":"Halozyme Therapeutics Hits Fresh Record After Increased $1.3 Bln Convertible Bond Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2668892177","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668892177?lang=en_us&edition=fundamental","pubTime":"2026-09-18 22:41","pubTimestamp":1789742496,"startTime":"0","endTime":"0","summary":"BUZZ-Halozyme Therapeutics hits fresh record after increased $1.3 bln convertible bond sale** Shares of Halozyme TherapeuticsHALO.Oup 0.8% at $110.55 and touch fresh record high on Fri after it secure","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL6N45A0WL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFOX","BK4139","HALO","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127833355","title":"Pound and Dollar Gold Prices Reflect Divergent Rate Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1127833355","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127833355?lang=en_us&edition=fundamental","pubTime":"2026-09-18 16:20","pubTimestamp":1789719650,"startTime":"0","endTime":"0","summary":"On September 18, gold's performance in different currencies highlighted the growing significance of foreign exchange dynamics. After the Bank of England held its interest rate steady on September 17,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","PHYS","TXXI","NUAG","MGBPmain","EVNT","VGFPF","GDXY","USG","JFLX","GDE","FNK","PALL","GOLY","UYM","SROI","CIK","PAYH","02840","IGLD","SLWS","DUST","JNUG","SGOL","IAU","GLL","UGLD","IAUI","SECR","IAUM","JAAA","QMY","IBCE","UGL","EVG","PYZ","NUGT","RING","BKLN","BEGS","SGDJ","BK4585","SCYB","OUNZ","FFOX","GDXU","GMOC","GBUG","DGZ","LQID","DULL","DBC","GLDY","XLBI","DGP","EPU","TAXX","CERY","GBPmain","SGDM","BK4207","BAR","DFLV","GOAU","BK4535","GLTR","BUCK","CMDT","FGLD","AAAU","IBHJ","KGLD","BCFN","GLD","BK4588","GDXD","VSHY","DZZ","CGUI","MFSB","GLDM","BTGD","GDX","JDST","MGCmain","GDXW","CEF","DVVY","FITZ","NANR","FXB","PFLD","FNCL","BUYO","KDRN","GDXJ","BGLD","SHNY","FGDL","THRV","YGLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668914384","title":"Halozyme Prices Upsized USD 1.3 Billion Convertible Senior Notes Offering Due 2033","url":"https://stock-news.laohu8.com/highlight/detail?id=2668914384","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668914384?lang=en_us&edition=fundamental","pubTime":"2026-09-18 11:20","pubTimestamp":1789701617,"startTime":"0","endTime":"0","summary":"Halozyme prices upsized USD 1.3 billion convertible senior notes offering due 2033Halozyme priced an upsized private offering of USD 1.3 billion 1.5% convertible senior notes due 2033.Deal increased f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL7blHh5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFOX","LU0053671581.USD","BK4139","HALO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":137,"code":"91000000","status":"200"}]}}